Distinct effects of knocking down MEK1 and MEK2 on replication of herpes simplex virus type 2

Virus Research

Volumn 150, Issue 1-2, 2010, Pages 22-27

  Zhang, Hao ^a,b   Feng, Hai ^a   Luo, Lingqi ^a   Zhou, Qi ^a   Luo, Zhijun ^c   Peng, Yihong ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ERK; HSV 2; MEK1; MEK2; SiRNA; Viral replication

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; SMALL INTERFERING RNA; VIRUS PROTEIN;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE SILENCING; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS REPLICATION;

BUTADIENES; CELL LINE; ENZYME INHIBITORS; GENE KNOCKOUT TECHNIQUES; GENE SILENCING; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 2; NITRILES; RNA, SMALL INTERFERING; VIRUS REPLICATION;

HUMAN HERPESVIRUS 2;

EID: 77952239377     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.02.007     Document Type: Article

References (42)

1. Belanger L.F., Roy S., Tremblay M., Brott B., Steff A.M., Mourad W., Hugo P., Erikson R., Charron J. Mek2 is dispensable for mouse growth and development. Mol. Cell. Biol. 2003, 23:4778-4787.
2. Brooks G.F., Brutel J.S., Morse S.A. Jaweta, Melnick, & Adelberg's Medical Microbiology 2004, McGraw Hill, New York. 23rd ed.
3. Cai Y., Liu Y., Zhang X. Suppression of coronavirus replication by inhibition of the MEK signaling pathway. J. Virol. 2007, 81:446-456.
4. Chambard J.C., Lefloch R., Pouyssegur J., Lenormand P. ERK implication in cell cycle regulation. Biochim. Biophys. Acta 2007, 1773:1299-1310.
5. Chang F., Steelman L.S., Shelton J.G., Lee J.T., Navolanic P.M., Blalock W.L., Franklin R., McCubrey J.A. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int. J. Oncol. 2003, 22:469-480. (review).
6. Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends Cell Biol. 1997, 7:353-361.
7. English J.M., Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 2002, 23:40-45.
8. Enslen H., Davis R.J. Regulation of MAP kinases by docking domains. Biol. Cell 2001, 93:5-14.
9. Giroux S., Tremblay M., Bernard D., Cardin-Girard J.F., Aubry S., Larouche L., Rousseau S., Huot J., Landry J., Jeannotte L., Charron J. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr. Biol. 1999, 9:369-372.
10. Hay J., Ruyechan W.T. Regulation of herpes simplex virus type 1 gene expression. Curr. Top. Microbiol. Immunol. 1992, 179:1-14.
11. Hill J., Roberts S. Herpes simplex virus in pregnancy: new concepts in prevention and management. Clin. Perinatol. 2005, 32:657-670.
12. Hunter J.C., Smith C.C., Bose D., Kulka M., Broderick R., Aurelian L. Intracellular internalization and signaling pathways triggered by the large subunit of HSV-2 ribonucleotide reductase (ICP10). Virology 1995, 210:345-360.
13. Jacque J.M., Mann A., Enslen H., Sharova N., Brichacek B., Davis R.J., Stevenson M. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 1998, 17:2607-2618.
14. Jelinek T., Catling A.D., Reuter C.W., Moodie S.A., Wolfman A., Weber M.J. RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2. Mol. Cell Biol. 1994, 14:8212-8218.
15. Kelemen B.R., Hsiao K., Goueli S.A. Selective in vivo inhibition of mitogen-activated protein kinase activation using cell-permeable peptides. J. Biol. Chem. 2002, 277:8741-8748.
16. King C.S., Cooper J.A., Moss B., Twardzik D.R. Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors. Mol. Cell Biol. 1986, 6:332-336.
17. Kohno M., Pouyssegur J. Targeting the ERK signaling pathway in cancer therapy. Ann. Med. 2006, 38:200-211.
18. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem. J. 2000, 351:289-305.
19. Ludwig S., Planz O., Pleschka S., Wolff T. Influenza-virus-induced signaling cascades: targets for antiviral therapy?. Trends Mol. Med. 2003, 9:46-52.
20. Luo H., Yanagawa B., Zhang J., Luo Z., Zhang M., Esfandiarei M., Carthy C., Wilson J.E., Yang D., McManus B.M. Coxsackievirus B3 replication is reduced by inhibition of the extracellular signal-regulated kinase (ERK) signaling pathway. J. Virol. 2002, 76:3365-3373.
21. McCubrey J.A., Steelman L.S., Chappell W.H., Abrams S.L., Wong E.W., Chang F., Lehmann B., Terrian D.M., Milella M., Tafuri A., Stivala F., Libra M., Basecke J., Evangelisti C., Martelli A.M., Franklin R.A. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim. Biophys. Acta 2007, 1773:1263-1284.
22. Morrison D.K., Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 2003, 19:91-118.
23. Panteva M., Korkaya H., Jameel S. Hepatitis viruses and the MAPK pathway: is this a survival strategy?. Virus Res. 2003, 92:131-140.
24. Perkins D., Pereira E.F., Gober M., Yarowsky P.J., Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J. Virol. 2002, 76:1435-1449.
25. Planz O., Pleschka S., Ludwig S. MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells. J. Virol. 2001, 75:4871-4877.
26. Pleschka S., Wolff T., Ehrhardt C., Hobom G., Planz O., Rapp U.R., Ludwig S. Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat. Cell Biol. 2001, 3:301-305.
27. Schaeffer H.J., Catling A.D., Eblen S.T., Collier L.S., Krauss A., Weber M.J. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 1998, 281:1668-1671.
28. Shakibaei M., Schulze-Tanzil G., de Souza P., John T., Rahmanzadeh M., Rahmanzadeh R., Merker H.J. Inhibition of mitogen-activated protein kinase induces apoptosis of human chondrocytes. J. Biol. Chem. 2001, 276:13289-13294.
29. Sizemore J.M., Lakeman F., Whitley R., Hughes A., Hook E.W. The spectrum of genital herpes simplex virus infection in men attending a sexually transmitted disease clinic. J. Infect. Dis. 2006, 193:905-911.
30. Skarpen E., Flinder L.I., Rosseland C.M., Orstavik S., Wierod L., Oksvold M.P., Skalhegg B.S., Huitfeldt H.S. MEK1 and MEK2 regulate distinct functions by sorting ERK2 to different intracellular compartments. FASEB J. 2008, 22:466-476.
31. Smith C.C., Nelson J., Aurelian L., Gober M., Goswami B.B. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J. Virol. 2000, 74:10417-10429.
32. Smith J.S., Herrero R., Bosetti C., Munoz N., Bosch F.X., Eluf-Neto J., Castellsague X., Meijer C.J., Van den Brule A.J., Franceschi S., Ashley R. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J. Natl. Cancer Inst. 2002, 94:1604-1613.
33. Sturgill T.W. MAP kinase: it's been longer than fifteen minutes. Biochem. Biophys. Res. Commun. 2008, 371:1-4.
34. Ussar S., Voss T. MEK1 and MEK2, different regulators of the G1/S transition. J. Biol. Chem. 2004, 279:43861-43869.
35. Wagner E.K., Guzowski J.F., Singh J. Transcription of the herpes simplex virus genome during productive and latent infection. Prog. Nucleic Acid Res. Mol. Biol. 1995, 51:123-165.
36. Ward P.L., Roizman B. Herpes simplex genes: the blueprint of a successful human pathogen. Trends Genet. 1994, 10:267-274.
37. Weir J.P. Regulation of herpes simplex virus gene expression. Gene 2001, 271:117-130.
38. Whitley R. Neonatal herpes simplex virus infection. Curr. Opin. Infect. Dis. 2004, 17:243-246.
39. Yamashita N., Morishima T. Neonatal herpes. Nippon Rinsho 2006, 64(Suppl. 3):268-271.
40. Yip-Schneider M.T., Schmidt C.M. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac. Pancreas 2003, 27:337-344.
41. Zhang W., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002, 12:9-18.
42. Zheng B., Fiumara P., Li Y.V., Georgakis G., Snell V., Younes M., Vauthey J.N., Carbone A., Younes A. MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood 2003, 102:1019-1027.